• Users Online: 261
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2015  |  Volume : 40  |  Issue : 3  |  Page : 138-142

Protein Z serum levels as a risk factor for acute ischemic stroke in patients with systemic lupus erythematosus: a comparison with diabetic cases

1 Department of Internal Medicine, Ain Shams University, Cairo, Egypt
2 Department of Rheumatology and Rehabilitation, Tanta University, Tanta, Egypt
3 Department of Neurology, Ain Shams University, Cairo, Egypt
4 Department of Rheumatology and Rehabilitation, Ain Shams University, Cairo, Egypt
5 Department of Biochemistry, Ain Shams University, Cairo, Egypt

Correspondence Address:
Alyaa A El-Sherbeny
10 Ahmed Saman Street, Mostafa El-Nahas Street, Nasr City, 11762, Cairo
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1110-1067.164734

Rights and Permissions

Introduction A number of clinical studies that explored the role of protein Z in coronary heart disease, ischemic stroke, and deep vein thrombosis patients have been published. Particularly in ischemic stroke, patients or at least subgroups of patients with low levels (in the convalescent phase of stroke) or high levels (in the acute phase of stroke) of protein Z have been associated with increased risk of stroke. Aim of the work This cross-sectional study aimed to investigate the role of protein Z in patients with systemic lupus erythematosus (SLE) and/or diabetes mellitus (DM) to determine the association between protein Z serum concentration and acute ischemic stroke in these patients. Patients and methods The study was carried out on selected 40 stroke patients divided into 20 patients with SLE and 20 without SLE, who were further divided equally into diabetic and nondiabetic patients. Assessment included demographic data (age, height, weight, and BMI), clinical examination, laboratory investigations including complete blood count, erythrocyte sedimentation rate, HbA1c, lipid profile, protein Z level, MRI-brain, and extracranial carotid duplex ultrasound. Results As regards protein Z levels, it was 4.4 ± 0.6 μg/ml in group I (DM+SLE), 3.0 ± 0.8 μg/ml in group II (SLE + no DM), 2.6 ± 0.8 μg/dl in group III (no SLE, no DM), and 1.1 ± 0.6 μg/dl in group IV (no SLE + DM), which demonstrated a significant difference between the four groups, with the highest protein Z serum level in group I. Conclusion Our study demonstrated an independent association between increasing blood levels of protein Z in SLE rather than in DM patients and an increased risk for ischemic stroke. However, it remains unclear whether elevated protein Z concentrations are a cause or a consequence of ischemic stroke.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded121    
    Comments [Add]    

Recommend this journal